Fly News Breaks for April 30, 2015
DXCM
Apr 30, 2015 | 08:24 EDT
Canaccord said it would use the weakness following mixed Q1 results in DexCom as a buying opportunity. The firm cited a one-time charge on the early approval of the G5 PLATINUM with SHARE as impacting gross margins. Canaccord reiterated its Buy rating and $69 price target on DexCom shares.
News For DXCM From the Last 2 Days
There are no results for your query DXCM